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ADIOLOGIC PATHOLOGIC CORRELATION / Gastrointestinal imaging
bdominal  inﬂammatory  myoﬁbroblastic  tumour
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Inﬂammatory  myoﬁbroblastic  tumours  (IMT)  are  inﬂammatory  pseudotumours.  They  are
rare  lesions  characterised  histologically  by  ﬁbroblast  proliferation  associated  with  reactive
inﬂammatory  cells,  mimicking  a  malignant  process.  Described  by  Brunn  for  the  ﬁrst  time
in  1939  in  the  lung,  one  of  their  preferred  sites,  they  can  affect  any  organ.
Observation
A  20-year-old  female  patient  consulted  for  an  impaired  general  condition,  nocturnal  sweat-
ing,  and  exertional  dyspnea.  Clinical  examination  revealed  a  hypogastric  mass.  Laboratory
tests  revealed  iron  deﬁciency  anaemia.  An  abdominopelvic  CT  scan  (Fig.  1)  showed  a
rounded  well-circumscribed  pelvic  lesion,  which  was  spontaneously  hypodense  relative  to
the  muscles.  There  was  intense  peripheral  contrast  enhancement,  due  to  the  presence  of
highly  vascularised  tissue.  The  central  area  remained  hypodense  in  the  venous  phase  (120  s)
suggesting  a  necrotic  or  ﬁbrous  area.  There  were  no  locoregional  lymphadenopathies.  A
single  large,  well-circumscribed  lesion  in  a  young  patient,  with  no  lymphadenopathy  or
organomegaly,  suggests  a  benign  tumour.  Complete  surgical  ablation  conﬁrmed  the  pres-
ence  of  a  lesion,  developing  from  the  greater  omentum,  measuring  7  cm,  with  many
congested  surface  vessels  and  a  central  ﬁbro-necrotic  area  (Fig.  2).  Histological  exam-
ination  found  myoﬁbroblastic  spindle  cells  associated  with  inﬂammatory  cell  inﬁltrates
(Fig.  3).  ALK  immunohistochemical  staining  was  positive.  The  diagnosis  was  thus  of  an  IMT.
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• IMTs,  which  may  occur  at  any  age,  but  are  mainly  seenAbdominal  inﬂammatory  myoﬁbroblastic  tumour  
Discussion
IMTs  are  rare  benign  lesions,  with  ubiquitous  develop-
ment  and  unknown  aetiology  [1].  These  lesions  have  been
reported  with  various  names:  inﬂammatory  pseudotumour,
plasma  cell  granuloma,  ﬁbroxanthoma,  pseudo-lymphoma,
histiocytoma,  xanthomatous  pseudotumour,  pseudosar-
comatous  ﬁbromyxoid  tumour,  and  even  inﬂammatory
Figure 1. Abdominopelvic axial spontaneous contrast CT (a): well-circ
to the muscles, associated with a small quantity of peritoneal effusion.
venous phase (120 s) (b): there is peripheral contrast enhancement with
Figure 2. Case no. 2. Macroscopic appearance after surgical ablation (a
and has many congested vessels on the surface. After sectioning (b), the
Figure 3. Case no. 2. Histological examination showed the presenc
lymphocytes and plasma cells (HES, × 40) (a). Immunohistochemical exp411
brosarcoma  [1,2]. The  most  prevalent  term  in  current  use
n  the  literature  is  inﬂammatory  myoﬁbroblastic  tumour.
Pseudotumours  can  be  divided  into  two  particular  types
3]:umscribed rounded pelvic lesion spontaneously hypodense relative
 Abdominopelvic axial CT after injection of contrast agent in the
 a central hypodense area.
): the lesion has developed at the expense of the greater omentum
 lesion is polymorphic with a central ﬁbronecrotic area (star).
e of myoﬁbroblastic spindle cells associated with inﬂammatory
ression with anti-ALK antibody (brown precipitate) (b).
in  children  and  young  adults,  with  clear  female  pre-
dominance.  The  clinical  symptoms  of  abdominal  IMT
are  non-speciﬁc:  alteration  in  general  condition,  fever,
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weight  loss,  malaise,  and  gastrointestinal  disorders.A
mass  may  be  felt  by  palpation.  Laboratory  results  some-
times  show  iron  deﬁciency  anaemia,  thrombocytosis,
or  polyclonal  hypergammaglobulinaemia.  The  common
immunohistological  characteristic  of  them  is  the  expres-
sion  of  the  ALK  gene,  found  in  50%  of  cases;
other  inﬂammatory  pseudotumours,  which  are  poorly
deﬁned.  They  are  reactive  ﬁbroblastic  or  myoﬁbroblas-
tic  proliferations  of  infectious  or  inﬂammatory  origin,  and
authentic  tumours,  which  are  benign  or  with  low-grade
malignancy.  The  following  clinical  and  histological  fea-
tures  should  point  towards  these  differential  diagnoses:
an  elderly  patient,  cutaneous  or  subcutaneous,  lymph
node,  spleen  or  bladder  involvement,  an  inﬁltrate  promi-
nently  consisting  of  lymphocytes,  moderate  to  severe
nuclear  atypia,  atypical  mitoses,  necrosis.
The  macroscopic  appearance  of  IMT  is  of  a slow-
rowing,  non-encapsulated,  frequently  single,  multilobar
ass,  which  is  ﬁrm  with  a  yellow  to  brownish  surface,
estroying  the  tissue  that  it  invades.  It  may  show  necrotic-
aemorrhagic  changes  and  calciﬁcations.  It  ranges  in  size
etween  1  and  20  cm  with  a  mean  of  7  cm  [3].  Under
he  microscope  it  contains  a  myoﬁbroblastic  slightly  atyp-
cal  spindle  cell  component  [4],  which  is  more  or  less
asciculated  in  a  hyaline  stroma,  associated  with  many
nﬂammatory  lymphocytes/plasma  cells.  There  is  little
itotic  activity.  Anaplastic  lymphoma  kinase  (ALK)  gene
xpression,  although  not  speciﬁc  to  IPT,  is  observed  in
pproximately  50%  of  cases.  The  ALK  gene  present  on  2p23,
s  involved  in  the  pathogenesis  of  this  lesion.  The  presence
f  clonal  rearrangements  of  this  gene  in  IMT  in  children  and
oung  adults  indicates  the  tumoral  character  of  the  lesion
ather  than  any  reactive  nature.
Abdominal  locations  are  very  variable:  liver,  spleen,  pan-
reas,  adrenal  glands,  retroperitoneal  space,  diaphragm,
esentery,  gastrointestinal  tract,  etc.  Mesenteric  and
mental  forms  are  the  most  frequently  encountered.
bdominal  locations  evolve  less  favourably  than  extra-
bdominal  locations,  with  23  to  37%  of  recurrence  [5].
Radiological  signs  are  poorly  deﬁned  because  of  the
olymorphism  of  IMTs:  only  small  series  of  cases  have
een  reported  and  multiphase  acquisitions  allowing  more
omplete  study  of  the  enhancement  kinetics  are  rarely
erformed  in  these  young  people  for  obvious  radiation
rotection  reasons.  There  is  usually  a  large  single  lesion,
xerting  a  mass  effect  on  adjacent  organs.  Its  margins  are
ore  or  less  well  deﬁned.  A  CT  scan  readily  shows  a  homo-
eneous  or  heterogeneous  lesion,  which  is  hypodense  or
sodense  relative  to  the  muscles.  Calciﬁcations  and  lym-
hadenomegalies  are  rare.  Contrast  uptake  is  variable  [6]:
nhancement  may  be  absent,  early  or  late,  homogeneous  or
[S.  Aptel  et  al.
ot,  and  peripheral  contrast  enhancement  may  show  central
ecrosis  or  ﬁbrosis.  The  same  signs  are  found  with  MRI.  This
an  be  explained  by  the  variable  composition  of  the  tissue
f  the  IMT,  including  a  ﬁbrous  component  corresponding  to
car  tissue.  The  time  for  uptake  of  contrast  agent  depends
n  the  vascular  component:  early  contrast  enhancement  in
he  case  of  young,  oedematous,  inﬂammatory  cellular  ﬁbro-
is;  delayed  contrast  enhancement  if  the  ﬁbrosis  is  mature
 collagen.  In  theory,  it  is  therefore  desirable  to  make  late
cquisitions,  to  highlight  late  contrast  enhancement,  even  if
t  is  discreet.  Given  the  problems  associated  with  irradiation
n  young  subjects,  non-irradiating  multiphase  exploration  is
referable,  such  as  MRI.  IMT  is  a  diagnosis  by  exclusion.  The
ifferential  diagnoses  include  non-tumour  lesions  such  as
bscesses  or  tuberculous  granulomas,  and  benign  or  malig-
ant  tumours.  A  desmoplastic  small  round  cell  tumour  is  a
alignant  tumour  in  the  young  with  a  poor  prognosis,  char-
cterised  by  a  single  or  multiple  peritoneal  mass  located  in
he  omentum  or  mesentery.  A  lymphoma  or  GIST  must  also
e  eliminated.
The  deﬁnitive  diagnosis  is  histological  and  treatment  is
urgical.  Local  or  regional  recurrence  is  possible  and  metas-
ases  are  rare.
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